Skip to content

OFA - Opioid Free Anesthesia

Study Protocol OFA: Opioid-Free Anesthesia.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03124082
Acronym
OFA
Enrollment
64
Registered
2017-04-21
Start date
2017-01-04
Completion date
2018-03-31
Last updated
2017-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Opioids have been used for analgesia since many years, but despite potent analgesia they are also associated to side effects, including opioid induced Hyperalgesia (OIH). OIH in the surgical setting is debated, and may predispose patients to higher analgesic consumption in the preoperative period, and peripheral and central sensitization. The aim of the study is to compare remifentanil-based vs non opioid analgesia (clonidine, lidocaine, ketamine) for intraoperative management of patients undergoing laparoscopic left hemicolectomy, with the hypothesis that non- opiod treated patients will have lower morphine consumption in the first 24 hours after surgery. Peripheral and central hyperalgesia will be tested with Von Frey hairs and pin-prick to evaluate acute CNS (Central Nervous System) sensitization after surgery. Acute and persistent (1 and 3 months) pain will be registered, together with any side effect and parameters of surgical rehabilitation.

Interventions

DRUGRemifentanil

continuous infusion intraop

DRUGKetamine

bolus 0,5 mg/kg + infusion 0,25 mg/kg/h

DRUGLidocaine

lidocaine bolus 1 mg/kg + infusion 1 mg/kg/h

DRUGClonidine

clonidine 4 mcg/kg

Sponsors

University of Parma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

randomized double blind trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* left hemicolectomy * signed informed consent * \>18 ys

Exclusion criteria

* \>90 ys \<18 ys * no consent * pregnancy * psychiatric disease * cardiac failure, aortic or mitral valve severe stenosis * kidney or hepatic failure * atrio-ventricular type II block * immunodepression * emergency surgery * ICU admittance * drug or alcohol abuse * chronic pain

Design outcomes

Primary

MeasureTime frameDescription
analgesic consumption24 HOURSmorphine mg by PCA (Patient Controlled Analgesia)

Secondary

MeasureTime frameDescription
side effects4 days after surgerynausea and vomiting, ileus, itching, shiver, hypotension, bradycardia, sedation
Pain Score on the Visual Analog Scale3 monthsVAS (Visual Analog Scale)
peripheral sensitization24 hoursassessment of primary hyperalgesia by Von Frey Filaments at 24 hours
central sensitization24 hoursassessment of secondary hyperalgesia by pin-prick test at 24 hours

Countries

Italy

Contacts

Primary ContactBugada Dario, MD
dariobugada@gmail.com+390521703567

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026